|
ZNF236 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.54259971252691E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.16267062223142E-13 |
| Normal-vs-Stage2 |
4.4430999990297E-08 |
| Normal-vs-Stage3 |
1.60879976007777E-10 |
| Normal-vs-Stage4 |
5.00050001406294E-10 |
| Stage1-vs-Stage2 |
4.937200E-01 |
| Stage1-vs-Stage3 |
1.099440E-01 |
| Stage1-vs-Stage4 |
1.721000E-01 |
| Stage2-vs-Stage3 |
6.457000E-01 |
| Stage2-vs-Stage4 |
5.867400E-01 |
| Stage3-vs-Stage4 |
8.911400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.68780039628325E-10 |
| Normal-vs-AfricanAmerican |
2.304100E-03 |
| Normal-vs-Asian |
1.56639999970842E-07 |
| Caucasian-vs-AfricanAmerican |
1.150010E-01 |
| Caucasian-vs-Asian |
6.038000E-01 |
| AfricanAmerican-vs-Asian |
3.037200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.37779948245532E-10 |
| Normal-vs-Female |
8.82700024185112E-10 |
| Male-vs-Female |
5.835800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.71099817542131E-11 |
| Normal-vs-Age(41-60Yrs) |
1.26743060491208E-12 |
| Normal-vs-Age(61-80Yrs) |
1.60250035463605E-10 |
| Normal-vs-Age(81-100Yrs) |
2.018500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.704400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.110840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.481790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.298400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.685400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.394000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.614000E-04 |
| Classical-VS-Follicular |
4.457800E-03 |
| Classical-VS-Other |
8.553600E-01 |
| Classical-VS-Normal |
6.56919999508787E-08 |
| Tall-VS-Follicular |
3.882600E-01 |
| Tall-VS-Other |
3.166200E-01 |
| Tall-VS-Normal |
2.69410049824614E-11 |
| Follicular-VS-Other |
4.721800E-01 |
| Follicular-VS-Normal |
7.98872079599278E-12 |
| Other-VS-Normal |
1.809810E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68594044175552E-14 |
| Normal-vs-N1 |
1.89809999939783E-08 |
| N0-vs-N1 |
7.578600E-01 |
|
|
